Trial intelligence / Profile preview

Paracetamol in mild asthma

ACTRN12610000729022Phase 4Not yet recruiting

Sponsor
Medical Research Institute of New Zealand
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in asthma comparing Paracetamol with Placebo (2 arms). Primary endpoints: Airways resistance at 5 Hz and Airways resistance at 20 Hz. Planned start Jan 2011; status: not yet recruiting.

02

Drugs

acetaminophen
03

Conditions

asthma

Beyond the preview

Go deeper on ACTRN12610000729022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610000729022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call